methamphetamine has been researched along with mirtazapine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 4 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Angle, JM; Dallimore, JE; Mackie, AR; McDaid, J; Mickiewicz, AL; Napier, TC; Shen, F; Tedford, CE | 1 |
| Blaszczyk, J; Cruickshank, CC; Dyer, KR; Montebello, ME; Quigley, A; Shand, D; Tomkins, S | 1 |
| Graham, MP; Harper, LK; Herrold, AA; Napier, TC; Shen, F; Specio, SE; Tedford, CE | 1 |
| Graves, SM; Napier, TC | 1 |
| Bhatia, KS; Fowler, JC; Lee, TH; Szabo, ST; Wetsel, WC | 1 |
| Mickiewicz, AL; Napier, TC; Voigt, RM | 1 |
| Colfax, GN; Das, M; Gasper, J; Matheson, T; Santos, DM; Santos, GM; Shoptaw, S; Vittinghoff, E | 1 |
| Graves, SM; Napier, TC; Rafeyan, R; Watts, J | 1 |
| Coffin, P; Colfax, G; Hermanstyne, KA; Santos, D; Santos, GM; Vittinghoff, E | 1 |
| Batki, SL; Coffin, PO; Colfax, G; Hern, J; Matheson, T; Santos, D; Santos, GM; Vittinghoff, E; Walker, JE | 1 |
| Ciccarone, D; Shoptaw, S | 1 |
| Dennis, B; Naji, L; Paul, J; Rosic, T; Samaan, Z; Thabane, L; Wiercioch, W; Worster, A | 1 |
| Flores, R; Fujimoto, K; Harawa, N; Hotton, A; Khanna, AS; Lee, F; Schneider, JA; Sheeler, D; Vecchio, ND | 1 |
4 review(s) available for methamphetamine and mirtazapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedside.
Topics: Animals; Antidepressive Agents, Tricyclic; Central Nervous System Stimulants; Conditioning, Psychological; Humans; Methamphetamine; Mianserin; Mirtazapine; Receptors, Serotonin; Substance-Related Disorders | 2012 |
Understanding Stimulant Use and Use Disorders in a New Era.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Anticonvulsants; Behavior Therapy; Bupropion; Central Nervous System Stimulants; Cocaine-Related Disorders; Cognitive Dysfunction; Comorbidity; Dopamine Uptake Inhibitors; Female; Humans; Illicit Drugs; Male; Mental Disorders; Methamphetamine; Mirtazapine; Neurobiology; Neurodegenerative Diseases; Opiate Overdose; Substance Withdrawal Syndrome; Topiramate; Transgender Persons; United States | 2022 |
Mirtazapine for the treatment of amphetamine and methamphetamine use disorder: A systematic review and meta-analysis.
Topics: Central Nervous System Stimulants; Female; Humans; Male; Methamphetamine; Mirtazapine; Remission Induction; Substance-Related Disorders | 2022 |
4 trial(s) available for methamphetamine and mirtazapine
| Article | Year |
|---|---|
A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
Topics: Adult; Ambulatory Care; Amphetamine-Related Disorders; Antidepressive Agents, Tricyclic; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methamphetamine; Mianserin; Mirtazapine; Psychiatric Status Rating Scales; Severity of Illness Index; Substance Withdrawal Syndrome; Time Factors | 2008 |
Mirtazapine to reduce methamphetamine use: a randomized controlled trial.
Topics: Adrenergic alpha-Antagonists; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Directive Counseling; Double-Blind Method; Drug Monitoring; Homosexuality, Male; Humans; Male; Medication Adherence; Methamphetamine; Mianserin; Middle Aged; Mirtazapine; Risk Factors; Sexual Behavior; Sexual Partners; Treatment Outcome; Urine Specimen Collection | 2011 |
Event-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Bupropion; Female; Humans; Logistic Models; Male; Medication Adherence; Methamphetamine; Mianserin; Middle Aged; Mirtazapine; Motivation; Substance Abuse Detection; Young Adult | 2014 |
Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial.
Topics: Adult; Amphetamine-Related Disorders; Double-Blind Method; Female; HIV Infections; Homosexuality, Male; Humans; Male; Medication Adherence; Methamphetamine; Mirtazapine; Transgender Persons; Unsafe Sex | 2020 |
9 other study(ies) available for methamphetamine and mirtazapine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Nullifying drug-induced sensitization: behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized rats.
Topics: Action Potentials; Adrenergic Agents; Adrenergic alpha-Antagonists; Animals; Dopamine; Electrochemistry; Globus Pallidus; Ketanserin; Locomotion; Male; Methamphetamine; Mianserin; Microelectrodes; Mirtazapine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic; Receptors, Dopamine D1; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 2007 |
Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference.
Topics: Adrenergic alpha-Antagonists; Animals; Blotting, Western; Central Nervous System Stimulants; Conditioning, Operant; Cues; Cyclic AMP Response Element-Binding Protein; Extracellular Signal-Regulated MAP Kinases; Male; Memory; Methamphetamine; Mianserin; Mirtazapine; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Signal Transduction; Taste | 2009 |
Mirtazapine alters cue-associated methamphetamine seeking in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Cues; Drug Interactions; Drug-Seeking Behavior; Extinction, Psychological; Male; Methamphetamine; Mianserin; Mirtazapine; Motor Activity; Rats; Rats, Sprague-Dawley; Self Administration | 2011 |
Reversal of long-term methamphetamine sensitization by combination of pergolide with ondansetron or ketanserin, but not mirtazapine.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Infusion Pumps, Implantable; Ketanserin; Male; Methamphetamine; Mianserin; Mirtazapine; Ondansetron; Pergolide; Rats; Rats, Sprague-Dawley | 2011 |
Repeated mirtazapine nullifies the maintenance of previously established methamphetamine-induced conditioned place preference in rats.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Central Nervous System Stimulants; Conditioning, Operant; Drug Administration Schedule; Male; Methamphetamine; Mianserin; Mirtazapine; Motor Activity; Rats; Rats, Sprague-Dawley; Time Factors | 2011 |
Stimulant use interventions may strengthen 'Getting to Zero' HIV elimination initiatives in Illinois: Insights from a modeling study.
Topics: Central Nervous System Stimulants; HIV Infections; Homosexuality, Male; Humans; Illinois; Male; Methamphetamine; Mirtazapine; Sexual and Gender Minorities | 2022 |